"LinXis soon to move into the Amsterdam UMC Imaging Center"

Read more


The Linxis management has developed its in-company IP strategy to ensure the protection of her proprietary Lx®-ADC technology with several patent applications.

Other patent applications for the ​Lx®-ADC technology are pending. In addition to these applications, Linxis will continue to investigate her Freedom to Operate and file patents protecting new developments and ADC products.

Methods for preparing cell targeting conjugates and conjugates obtainable by said methods.

June 2019

​Link to Espacenet

Platinum-based functional moieties for preparing cell-targeting conjugates.

June 2019

Link to Espacenet

Method for removing weakly bound functional moieties from cell targeting conjugates.

September 2016

Method for preparing cell targeting conjugates, and the complexes obtained.

July 2013